Global Flexible Endoscopes Market

Global Flexible Endoscopes Market Size, Share, Growth Analysis, By Type(Laparoscopes, Arthroscopes), By End-Use(Hospitals and Outpatient Facilities) - Industry Forecast 2024-2031


Report ID: SQMIG35A2538 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 75 | Figures: 75

Global Flexible Endoscopes Market News

  • In August 2021, The EXALT Model B, a Single-Use Bronchoscope from Boston Scientific received FDA approval. The single-use EXALT Model B bronchoscope is the most recent advancement in flexible bronchoscopy.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Flexible Endoscopes Market size was valued at USD 8.96 Billion in 2022 and is poised to grow from USD 9.64 Billion in 2023 to USD 17.32 Billion by 2031, at a 7.6% during the forecast period (2024-2031).

The increased demand for flexible endoscopes for various therapeutic and diagnostic procedures has created fierce rivalry among the market's current players. The competition is also growing as a result of technological developments made by important competitors in the field of endoscope tools. 'Olympus Corporation', 'Fujifilm Holdings Corporation', 'Medtronic plc', 'Karl Storz SE & Co. KG', 'Stryker Corporation', 'Boston Scientific Corporation', 'Pentax Medical Company (Hoya Corporation)', 'Richard Wolf GmbH', 'Ambu A/S', 'Cook Medical LLC', 'HOYA Corporation', 'Smith & Nephew plc', 'Conmed Corporation', 'EndoChoice Holdings, Inc. (Beijing Hangwei Medical Systems Co., Ltd.)', 'Applied Medical Resources Corporation', 'Fujifilm Medical Systems USA, Inc.', 'Vimex Sp. z o.o.', 'GIMMI GmbH', 'Maxer Endoscopy GmbH', 'Schölly Fiberoptic GmbH'

The rising incidence of gastrointestinal diseases, such as colorectal cancer, gastrointestinal bleeding, and inflammatory bowel disease, is driving the demand for flexible endoscopes. These devices are essential for the diagnosis, treatment, and monitoring of various gastrointestinal conditions, thereby fueling market growth.

Increasing adoption of minimally invasive procedures: The market for flexible endoscopes is witnessing a significant trend towards minimally invasive procedures. These procedures offer benefits such as reduced patient discomfort, shorter recovery times, and lower healthcare costs. The growing preference for minimally invasive techniques among patients and healthcare providers is driving the demand for flexible endoscopes.

North America dominated the adaptable endoscopes market or accounted for the largest revenue share of 40.6% in 2022 as a result of an increase in chronic illnesses that necessitate their use, including irritable bowel syndrome, colorectal and stomach cancer, and those that cause the stomach and. Studies estimate that 12% of Americans have irritable bowel syndrome. By 2021, 16.5% of the population in the region will be 65 or older, an increase in an aging population which is more susceptible to chronic diseases. This number is anticipated to rise to 20% by 2050, aiding market expansion.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Flexible Endoscopes Market

Product ID: SQMIG35A2538

$5,300
BUY NOW GET FREE SAMPLE